These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22432709)

  • 1. Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis.
    Barreteau H; El Ghachi M; Barnéoud-Arnoulet A; Sacco E; Touzé T; Duché D; Gérard F; Brooks M; Patin D; Bouhss A; Blanot D; van Tilbeurgh H; Arthur M; Lloubès R; Mengin-Lecreulx D
    Microb Drug Resist; 2012 Jun; 18(3):222-9. PubMed ID: 22432709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colicin M, a peptidoglycan lipid-II-degrading enzyme: potential use for antibacterial means?
    Touzé T; Barreteau H; El Ghachi M; Bouhss A; Barnéoud-Arnoulet A; Patin D; Sacco E; Blanot D; Arthur M; Duché D; Lloubès R; Mengin-Lecreulx D
    Biochem Soc Trans; 2012 Dec; 40(6):1522-7. PubMed ID: 23176510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CbrA Mediates Colicin M Resistance in Escherichia coli through Modification of Undecaprenyl-Phosphate-Linked Peptidoglycan Precursors.
    Barreteau H; Patin D; Bouhss A; Blanot D; Mengin-Lecreulx D; Touzé T
    J Bacteriol; 2020 Nov; 202(23):. PubMed ID: 32958631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human- and plant-pathogenic Pseudomonas species produce bacteriocins exhibiting colicin M-like hydrolase activity towards peptidoglycan precursors.
    Barreteau H; Bouhss A; Fourgeaud M; Mainardi JL; Touzé T; Gérard F; Blanot D; Arthur M; Mengin-Lecreulx D
    J Bacteriol; 2009 Jun; 191(11):3657-64. PubMed ID: 19346308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural characterization of PaeM, a colicin M-like bacteriocin produced by Pseudomonas aeruginosa.
    Barreteau H; Tiouajni M; Graille M; Josseaume N; Bouhss A; Patin D; Blanot D; Fourgeaud M; Mainardi JL; Arthur M; van Tilbeurgh H; Mengin-Lecreulx D; Touzé T
    J Biol Chem; 2012 Oct; 287(44):37395-405. PubMed ID: 22977250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis.
    Burkard M; Stein T
    J Microbiol Methods; 2008 Sep; 75(1):70-4. PubMed ID: 18558445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colicin M inhibits peptidoglycan biosynthesis by interfering with lipid carrier recycling.
    Harkness RE; Braun V
    J Biol Chem; 1989 Apr; 264(11):6177-82. PubMed ID: 2649496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and uptake mechanism of bacteriocins targeting peptidoglycan renewal.
    Zeth K
    Biochem Soc Trans; 2012 Dec; 40(6):1560-5. PubMed ID: 23176517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
    Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
    Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis.
    Sham LT; Butler EK; Lebar MD; Kahne D; Bernhardt TG; Ruiz N
    Science; 2014 Jul; 345(6193):220-2. PubMed ID: 25013077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.
    de Kruijff B; van Dam V; Breukink E
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):117-21. PubMed ID: 19008088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate analogues to study cell-wall biosynthesis and its inhibition.
    Lazar K; Walker S
    Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Import of periplasmic bacteriocins targeting the murein.
    Braun V; Helbig S; Patzer SI
    Biochem Soc Trans; 2012 Dec; 40(6):1449-55. PubMed ID: 23176497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro peptidoglycan synthesis by envelopes from Escherichia coli tolM mutants is inhibited by colicin M.
    Harkness RE; Braun V
    J Bacteriol; 1990 Jan; 172(1):498-500. PubMed ID: 2152914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology. A flipping cell wall ferry.
    Young KD
    Science; 2014 Jul; 345(6193):139-40. PubMed ID: 25013047
    [No Abstract]   [Full Text] [Related]  

  • 20. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.